US Building Permits Prel (Oct MM) -7.4% (Prev. -0.4%)
Newsquawk Staff ·
US Building Permits Prel (Oct MM) -7.4% (Prev. -0.4%)
What it means
A decline of this size in building permits is large relative to the series' normal month-to-month noise and points to a softening pipeline of residential construction rather than completed activity, since permits lead starts and the start-to-completion chain by a meaningful lag. Preliminary prints of this kind are subject to revision at the final read, which has on past occasions closed part of the gap, so the confirmation arrives with the revised figure and the following month's release rather than with this headline. A single weak month is distinguished from a genuine downturn by whether the decline is broad-based across single and multifamily or concentrated in the volatile multifamily component, which has historically driven outsized monthly swings without signalling a trend break. Rates have typically been the transmission channel: permits track mortgage rate moves with a lag, and in past episodes of sharp rate repricing the series has weakened before the broader housing data followed. The follow-ons are the housing starts and new home sales prints and any corroboration from homebuilder sentiment, with the long end of the curve and rate-sensitive equities the usual recipients of a deteriorating housing signal.
- US PREMARKET MOVERS: NVDA, TJX, LOW, FCX, TTWO, TGT, FIX, AAOI, DLB
- PRIMER - Today’s Fedspeak (18th November 2026) includes: Daly, Barr, Williams, Kashkari; FOMC meeting minutes are also released
- [MARKET ANALYSIS] DXY remains firmer, GBP lags post-CPI but money markets continue to price in a hike in December
- Daily US Equity Opening News - NVDA up after results; AAPL restores systems after outage; MRVL & CRDO settle patent disputes; GOOG’s Waymo suspends California freeway operations; TTWO GTA VI pre-orders said to reach 15.88mln; TCEHY sales miss
- EUROPEAN OPEN: NVDA higher after results; ENOG LN talks for BP/ LN Egypt assets stall; GSK LN Nelkarmi wins accelerated FDA approval; Brazil challenges EU review of AAL LN nickel sale; ALO FP posts H1 loss, launches debt plan
Related headlines
- US Building Permits Prel (Oct) 1.295M vs. Exp. 1.38M (Prev. 1.398M)20 min ago
- US Housing Starts (Oct) 1.309M vs. Exp. 1.25M (Prev. 1.221M)20 min ago
- US Housing Starts (Oct MM) 9.9% (Prev. -5.2%)20 min ago
- UBS expects Brent at USD 80/bbl by end-2027, assuming supply pressures ease34 min ago
- NVIDIA (NVDA) former CEO Huang and US Commerce Secretary Lutnick have both agreed to appear before a Senate panel, according to Republican Senator Scott34 min ago
- Saudi Arabia reportedly expects its conflict with the Houthis to extend well into 2027, Reuters sources say41 min ago
- [MARKET UPDATE]: Hawkish reaction as Fed Governor Waller reiterates possibility of a 50bps rate hike; upside in UST yields and the Dollar, while equities and gold fall1 hour ago
- Fed’s Waller (voter), speaking on CNBC, says he is very worried inflation is moving in the wrong direction and broadening; the Fed needs to act more aggressively if it wants to bring inflation down1 hour ago
- Textron (TXT) entered into a definitive agreement to sell its Industrial segment to Kingswood Capital Management for USD 1.2bln1 hour ago
- Mexican President Sheinbaum says her meeting with US President Trump was very productive; We continue to make progress on our shared agenda1 hour ago
- TJX (TJX) Q3 FY27 (USD): Adj. EPS 1.34 (exp. 1.34), Revenue 16bln (exp. 15.8bln)1 hour ago
- US MBA Purchase Index (Nov/13) 137.6 (Prev. 141.2)1 hour ago
- US MBA 30-Year Mortgage Rate (Nov/13) 7.35% (Prev. 7.21%)1 hour ago
- US MBA Mortgage Market Index (Nov/13) 199.8 (Prev. 204.6)1 hour ago
- US MBA Mortgage Refinance Index (Nov/13) 532.8 (Prev. 540.7)1 hour ago